STOCK TITAN

Thermo Fisher Scientific Inc. - TMO STOCK NEWS

Welcome to our dedicated news page for Thermo Fisher Scientific (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fisher Scientific.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Thermo Fisher Scientific's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Thermo Fisher Scientific's position in the market.

Rhea-AI Summary
Thermo Fisher Scientific (NYSE: TMO) will host its 2024 Investor Day on September 19 in New York City. The event will include presentations by senior management and a Q&A session, with a live webcast accessible on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
conferences
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. reported strong financial results for the first quarter of 2024, with revenues of $10.34 billion. The company saw a 4% increase in GAAP diluted EPS and a 2% increase in adjusted EPS. Thermo Fisher launched innovative new products, expanded its services, and collaborated with customers to develop companion diagnostics. The company also repurchased $3.0 billion of stock and increased its dividend by 11%. Despite a 3% decline in revenue, Thermo Fisher raised its full-year revenue and adjusted EPS guidance for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) will release its Q1 2024 financial results on April 24, 2024, followed by a conference call to discuss financial performance and future expectations. Investors can access the call via phone or the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.02%
Tags
Rhea-AI Summary
Thermo Fisher Scientific Inc. extends the expiration time of the tender offer to acquire Olink Holding AB for $26.00 per Share and per ADS, in cash. Approximately 95.2% of outstanding Shares have been tendered. Completion of the Offer is subject to SEC conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
none
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) CEO to present at TD Cowen Health Care Conference on March 6, 2024. Webcast available on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
conferences
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) increases quarterly dividend by 11% to $0.39 per share, payable on April 15, 2024, to shareholders of record as of March 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
dividends
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) reported Q4 revenue of $10.89 billion, 5% lower than the previous year. Full-year revenue was $42.86 billion, also 5% lower. GAAP diluted EPS for Q4 was $4.20, 5% higher than last year, with an adjusted EPS of $5.67, also 5% higher. The company strengthened its industry leadership, launched innovative products, and expanded its global presence. Thermo Fisher executed its capital deployment strategy, completed key acquisitions, and returned $3.5 billion to shareholders. The company initiated a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) has extended the expiration time of the offering period to acquire all outstanding common shares and American Depositary Shares of Olink Holding AB (publ) for $26.00 per Share and per ADS, in cash. Approximately 94.1% of the outstanding Shares have been tendered and not properly withdrawn pursuant to the Offer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.61%
Tags
none
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) to Present at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
conferences
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) will release its Q4 and full year 2023 financial results on January 31, 2024, followed by a conference call to discuss its financial performance and future expectations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
Thermo Fisher Scientific Inc.

NYSE:TMO

TMO Rankings

TMO Stock Data

215.76B
380.42M
0.18%
92.21%
0.68%
Other Measuring and Controlling Device Manufacturing
Manufacturing
Link
US
Waltham

About TMO

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.